1. Postuma, RB, Berg, D, Stern, M, et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. 2015;30(12):1591–1601.
Google Scholar | Crossref | Medline2. Aarsland, D, Zaccai, J, Brayne, C. A systematic review of prevalence studies of dementia in Parkinson’s disease. Mov Disord. 2005;20(10):1255–1263.
Google Scholar | Crossref | Medline | ISI3. Nicoletti, A, Luca, A, Baschi, R, et al. Incidence of mild cognitive impairment and dementia in Parkinson’s disease: the Parkinson’s disease cognitive impairment study. Front Aging Neurosci. 2019;11:21.
Google Scholar | Crossref | Medline4. Aarsland, D, Bronnick, K, Williams-Gray, C, et al. Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology. 2010;75(12):1062–1069.
Google Scholar | Crossref | Medline | ISI5. Hely, MA, Reid, WG, Adena, MA, Halliday, GM, Morris, JG. The Sydney Multicenter Study of Parkinson’s Disease: the inevitability of dementia at 20 years. Mov Disord. 2008;23(6):837–844.
Google Scholar | Crossref | Medline | ISI6. Hoogland, J, Boel, JA, de Bie, RMA, et al. Risk of Parkinson’s disease dementia related to level I MDS PD-MCI. Mov Disord. 2019;34(3):430–435.
Google Scholar | Crossref | Medline7. Goldman, JG, Vernaleo, BA, Camicioli, R, et al. Cognitive impairment in Parkinson’s disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health. NPJ Parkinsons Dis. 2018;4:19.
Google Scholar | Crossref | Medline8. Vossius, C, Larsen, JP, Janvin, C, Aarsland, D. The economic impact of cognitive impairment in Parkinson’s disease. Mov Disord. 2011;26(8):1541–1544.
Google Scholar | Crossref | Medline9. Kehagia, AA, Barker, RA, Robbins, TW. Cognitive impairment in Parkinson’s disease: the dual syndrome hypothesis. Neurodegener Dis. 2013;11(2):79–92.
Google Scholar | Crossref | Medline | ISI10. Williams-Gray, CH, Evans, JR, Goris, A, et al. The distinct cognitive syndromes of Parkinson’s disease: 5 year follow-up of the CamPaIGN cohort. Brain. 2009;132(Pt 11):2958–2969.
Google Scholar | Crossref | Medline | ISI11. Hu, M, Cooper, J, Beamish, R, et al. How well do we recognise non-motor symptoms in a British Parkinson’s disease population? J Neurol. 2011;258(8):1513–1517.
Google Scholar | Crossref | Medline12. Dubois, B, Burn, D, Goetz, C, et al. Diagnostic procedures for Parkinson’s disease dementia: recommendations from the Movement Disorder Society Task Force. Mov Disord. 2007;22(16):2314–2324.
Google Scholar | Crossref | Medline | ISI13. Litvan, I, Goldman, JG, Troster, AI, et al. Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force Guidelines. Mov Disord. 2012;27(3):349–356.
Google Scholar | Crossref | Medline | ISI14. Skorvanek, M, Goldman, JG, Jahanshahi, M, et al. Global scales for cognitive screening in Parkinson’s disease: critique and recommendations. Mov Disord. 2018;33(2):208–218.
Google Scholar | Crossref | Medline15. Pagonabarraga, J, Kulisevsky, J, Llebaria, G, Garcia-Sanchez, C, Pascual-Sedano, B, Gironell, A. Parkinson’s disease-cognitive rating scale: a new cognitive scale specific for Parkinson’s disease. Mov Disord. 2008;23(7):998–1005.
Google Scholar | Crossref | Medline | ISI16. Pedraza, O, Mungas, D. Measurement in cross-cultural neuropsychology. Neuropsychol Rev. 2008;18(3):184–193.
Google Scholar | Crossref | Medline17. Aretouli, E, Brandt, J. Episodic memory in dementia: characteristics of new learning that differentiate Alzheimer’s, Huntington’s, and Parkinson’s diseases. Arch Clin Neuropsychol. 2010;25(5):396–409.
Google Scholar | Crossref | Medline18. Kudlicka, A, Clare, L, Hindle, JV. Executive functions in Parkinson’s disease: systematic review and meta-analysis. Mov Disord. 2011;26(13):2305–2315.
Google Scholar | Crossref | Medline | ISI19. Hughes, AJ, Daniel, SE, Kilford, L, Lees, AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55(3):181–184.
Google Scholar | Crossref | Medline | ISI20. Folstein, MF, Folstein, SE, McHugh, PR. Mini-Mental State. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–198.
Google Scholar | Crossref | Medline | ISI21. Hoehn, MM . The natural history of Parkinson’s disease in the pre-levodopa and post-levodopa eras. Neurol Clin. 1992;10(2):331–339.
Google Scholar | Crossref | Medline22. Hoehn, MM, Yahr, MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17(5):427–442.
Google Scholar | Crossref | Medline | ISI23. Hamilton, M . A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56–62.
Google Scholar | Crossref | Medline | ISI24. Jankovic, J, McDermott, M, Carter, J, et al. Variable expression of Parkinson’s disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology. 1990;40(10):1529–1534.
Google Scholar | Crossref | Medline25. Tabachnick, BG, Fidell, LS. Using Multivariate Statistics. 5th ed. Allyn & Bacon/Pearson Education; 2007.
Google Scholar26. Koevoets, EW, Schmand, B, Geurtsen, GJ. Accuracy of two cognitive screening tools to detect mild cognitive impairment in Parkinson’s disease. Mov Disord Clin Pract. 2018;5(3):259–264.
Google Scholar | Crossref | Medline27. Santangelo, G, Lagravinese, G, Battini, V, et al. The Parkinson’s disease-cognitive rating scale (PD-CRS): normative values from 268 healthy Italian individuals. Neurol Sci. 2017;38(5):845–853.
Google Scholar | Crossref | Medline28. Martinez-Martin, P, Prieto-Jurczynska, C, Frades-Payo, B. Psychometric attributes of the Parkinson’s disease-cognitive rating scale. An independent validation study [in Spanish]. Rev Neurol. 2009;49(8):393–398.
Google Scholar | Medline29. Fernandez de Bobadilla, R, Pagonabarraga, J, Martinez-Horta, S, Pascual-Sedano, B, Campolongo, A, Kulisevsky, J. Parkinson’s disease-cognitive rating scale: psychometrics for mild cognitive impairment. Mov Disord. 2013;28(10):1376–1383.
Google Scholar | Crossref | Medline30. Emre, M . What causes mental dysfunction in Parkinson’s disease? Mov Disord. 2003;18(suppl 6):S63–S71.
Google Scholar | Crossref | Medline | ISI31. Paula, JJ, Miranda, DM, Moraes, EN, Malloy-Diniz, LF. Mapping the clockworks: what does the Clock Drawing Test assess in normal and pathological aging? Arq Neuropsiquiatr. 2013;71(10):763–768.
Google Scholar | Crossref | Medline | ISI32. Cosentino, S, Jefferson, A, Chute, DL, Kaplan, E, Libon, DJ. Clock drawing errors in dementia: neuropsychological and neuroanatomical considerations. Cogn Behav Neurol. 2004;17(2):74–84.
Google Scholar | Crossref | Medline33. Thomann, PA, Toro, P, Dos Santos, V, Essig, M, Schroder, J. Clock drawing performance and brain morphology in mild cognitive impairment and Alzheimer’s disease. Brain Cogn. 2008;67(1):88–93.
Google Scholar | Crossref | Medline34. Talwar, NA, Churchill, NW, Hird, MA, et al. The neural correlates of the clock-drawing test in healthy aging. Front Hum Neurosci. 2019;13:25.
Google Scholar | Crossref | Medline35. Pinto, E, Peters, R. Literature review of the clock drawing test as a tool for cognitive screening. Dement Geriatr Cogn Disord. 2009;27(3):201–213.
Google Scholar | Crossref | Medline36. Grossman, M, McMillan, C, Moore, P, et al. What’s in a name: voxel-based morphometric analyses of MRI and naming difficulty in Alzheimer’s disease, frontotemporal dementia and corticobasal degeneration. Brain. 2004;127(pt 3):628–649.
Google Scholar | Medline37. Mack, J, Marsh, L . Parkinson’s disease: cognitive impairment. Focus (Am Psychiatr Publ). 2017;15(1):42–54.
Google Scholar | Medline38. Schneider, JS, Sendek, S, Yang, C. Relationship between motor symptoms, cognition, and demographic characteristics in treated mild/moderate Parkinson’s disease. PLoS One. 2015;10(4):e0123231.
Google Scholar | Crossref | Medline39. Szewczyk-Krolikowski, K, Tomlinson, P, Nithi, K, et al. The influence of age and gender on motor and non-motor features of early Parkinson’s disease: initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort. Parkinsonism Relat Disord. 2014;20(1):99–105.
Google Scholar | Crossref | Medline40. Aarsland, D, Kvaloy, JT, Andersen, K, et al. The effect of age of onset of PD on risk of dementia. J Neurol. 2007;254(1):38–45.
Google Scholar | Crossref | Medline | ISI